1. 1874 Phase 1b/2 study results for masitinib plus gemcitabine and carboplatin in advanced triple negative breast cancer. (September 2015) Authors: Campone, M.; Ferrero, J.M.; Gunzer, K.; Priou, F.; Dubreuil, P.; Mansfield, C.; Moussy, A.; Hermine, O. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IBRUTINIB IN ASSOCIATION WITH R‐DHAP/OX FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE BIBLOS PHASE IB LYSA STUDY. (June 2017) Authors: Bonnet, C.M.; Lamy, T.; Fruchart, C.; Legouill, S.; Gunzer, K.; Gastinne, T.; Jardin, F.; Karlin, L.; Houot, R.; Dupuis, J.; Tilly, H.; Salles, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗